Literature DB >> 8988423

Measurement of optic nerve head circulation: comparison of laser speckle and hydrogen clearance methods.

T Sugiyama1, T Utsumi, I Azuma, H Fujii.   

Abstract

Microcirculation in the optic nerve head (ONH) in the ocular fundus was measured noninvasively using the recently developed laser speckle circulation analyzer. Results were compared with capillary blood flow (CBF) measurements made by the hydrogen clearance method. The ONH blood flow of six normal rabbits was measured simultaneously by both methods. Inhalation of 10% carbon dioxide (CO2) increased the CBF by 22% (hydrogen clearance method). Intravenous injection of endothelin-1 (ET-1) (10(-10) mol/kg) decreased the CBF by 19%. Significant correlations were found between the NB (normalized blur) value by the laser speckle method and CBF (r = 0.38, P < 0.05, n = 30) and also between the relative change of NB and CBF (r = 0.92, P < 0.01, n = 30) in the ONH. This indicates that evaluation of the NB change in the ONH is as accurate with the laser speckle method as with the hydrogen clearance method, giving a basis for the clinical application of the laser speckle method of measuring ONH circulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8988423

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  29 in total

1.  Astaxanthin increases choroidal blood flow velocity.

Authors:  Michiyuki Saito; Kazuhiko Yoshida; Wataru Saito; Akio Fujiya; Kazuhiro Ohgami; Nobuyoshi Kitaichi; Hiroki Tsukahara; Susumu Ishida; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-10       Impact factor: 3.117

2.  Plasma endothelin-1 levels depress optic nerve head circulation detected during the glucose tolerance test.

Authors:  Teruyo Kida; Tetsuya Sugiyama; Hidehiro Oku; Seiyo Harino; Tsunehiko Ikeda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-17       Impact factor: 3.117

3.  Laser speckle flowgraphy for differentiating between nonarteritic ischemic optic neuropathy and anterior optic neuritis.

Authors:  Tomoyuki Maekubo; Hideki Chuman; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2013-05-22       Impact factor: 2.447

4.  The association between systemic oxidative stress and ocular blood flow in patients with normal-tension glaucoma.

Authors:  Noriko Himori; Hiroshi Kunikata; Yukihiro Shiga; Kazuko Omodaka; Kazuichi Maruyama; Hidetoshi Takahashi; Toru Nakazawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-30       Impact factor: 3.117

Review 5.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

6.  Effects of scleral buckling and encircling procedures on human optic nerve head and retinochoroidal circulation.

Authors:  M Nagahara; Y Tamaki; M Araie; S Eguchi
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

7.  Vasodilatory effect of L-arginine on isolated rabbit and human posterior ciliary arteries in vitro and increased optic disc blood flow in vivo.

Authors:  Hideki Chuman; Takako Sugimoto; Nobuhisa Nao-I
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-10-23       Impact factor: 3.117

8.  Anterior and posterior optic nerve head blood flow in nonhuman primate experimental glaucoma model measured by laser speckle imaging technique and microsphere method.

Authors:  Lin Wang; Grant A Cull; Chelsea Piper; Claude F Burgoyne; Brad Fortune
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-17       Impact factor: 4.799

9.  Optic nerve head blood flow response to reduced ocular perfusion pressure by alteration of either the blood pressure or intraocular pressure.

Authors:  Lin Wang; Grant A Cull; Brad Fortune
Journal:  Curr Eye Res       Date:  2014-06-09       Impact factor: 2.424

10.  Ocular microcirculation changes, measured with laser speckle flowgraphy and optical coherence tomography angiography, in branch retinal vein occlusion with macular edema treated by ranibizumab.

Authors:  Toshifumi Asano; Hiroshi Kunikata; Masayuki Yasuda; Koji M Nishiguchi; Toshiaki Abe; Toru Nakazawa
Journal:  Int Ophthalmol       Date:  2020-09-07       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.